Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 871 AL 885

A critical appraisal of MAO-B inhibitors in the treatment of Parkinson's disease

Jost WH.

J Neural Transm (Vienna). 2022 Jun;129(5-6):723-736. doi: 10.1007/s00702-022-02465-w. Epub 2022 Feb 2.

Moving Forward from the COVID-19 Pandemic: Needed Changes in Movement Disorders Care and Research

Valdovinos BY, Modica JS, Schneider RB.

Curr Neurol Neurosci Rep. 2022 Feb;22(2):113-122. doi: 10.1007/s11910-022-01178-7. Epub 2022 Feb 2.

The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies

Zalpoor H, Akbari A, Samei A, Forghaniesfidvajani R, Kamali M, Afzalnia A, Manshouri S, Heidari F, Pornour M, Khoshmirsafa M, Aazami H, Seif F.

Cell Mol Biol Lett. 2022 Feb 2;27(1):10. doi: 10.1186/s11658-022-00311-1.

Comparison of cardiovascular magnetic resonance characteristics and clinical prognosis in left ventricular noncompaction patients with and without arrhythmia

Zhou ZQ, He WC, Li X, Bai W, Huang W, Hou RL, Wang YN, Guo YK.

BMC Cardiovasc Disord. 2022 Feb 2;22(1):25. doi: 10.1186/s12872-022-02470-7.

A Phase I, First-in-Human, Healthy Volunteer Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN424, a Novel G Protein-Coupled Receptor 6 Inverse Agonist for Parkinson's Disease

Margolin DH, Brice NL, Davidson AM, Matthews KL, Carlton MBL.

J Pharmacol Exp Ther. 2022 Apr;381(1):33-41. doi: 10.1124/jpet.121.000842. Epub 2022 Feb 2.

The application of artificial intelligence and custom algorithms with inertial wearable devices for gait analysis and detection of gait-altering pathologies in adults: A scoping review of literature

Lim ACY, Natarajan P, Fonseka RD, Maharaj M, Mobbs RJ.

Digit Health. 2022 Jan 27;8:20552076221074128. doi: 10.1177/20552076221074128. eCollection 2022 Jan-Dec.

Comparison of pramipexole versus ropinirole in the treatment of Parkinson's disease

Gencler OS, Oztekin N, Oztekin MF.

Ideggyogy Sz. 2022 Jan 30;75(1-02):39-49. doi: 10.18071/isz.75.0039.

Effects of Endurance Training on Motor Signs of Parkinson's Disease: A Systematic Review and Meta-Analysis

de Almeida FO, Santana V, Corcos DM, Ugrinowitsch C, Silva-Batista C.

Sports Med. 2022 Aug;52(8):1789-1815. doi: 10.1007/s40279-022-01650-x. Epub 2022 Feb 3.

Ticagrelor for prevention of stroke and cognitive impairment in patients with vascular high-risk factors: A meta-analysis of randomized controlled trials

Li X, Jia Z, Yan Y.

Int J Cardiol. 2022 Apr 15;353:96-102. doi: 10.1016/j.ijcard.2022.01.060. Epub 2022 Jan 31.

What's in the Sauce? The Specific Benefits of Palliative Care for Parkinson's Disease

Bock M, Katz M, Sillau S, Adjepong K, Yaffe K, Ayele R, Macchi ZA, Pantilat S, Miyasaki JM, Kluger B.

J Pain Symptom Manage. 2022 Jun;63(6):1031-1040. doi: 10.1016/j.jpainsymman.2022.01.017. Epub 2022 Jan 31.

Mitochondrial DNA homeostasis impairment and dopaminergic dysfunction: A trembling balance

Manini A, Abati E, Comi GP, Corti S, Ronchi D.

Ageing Res Rev. 2022 Apr;76:101578. doi: 10.1016/j.arr.2022.101578. Epub 2022 Jan 31.

Neuropsychiatric Treatments for Parkinson's Disease: Nonpharmacological Approaches

Mathur N, Bhatt H, Lidstone SC.

Semin Neurol. 2022 Apr;42(2):158-167. doi: 10.1055/s-0041-1742266. Epub 2022 Feb 3.

Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches

Huang Y, Wei J, Cooper A, Morris MJ.

Genes Dis. 2022 Feb 5;10(3):786-798. doi: 10.1016/j.gendis.2021.12.015. eCollection 2023 May.

iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders

Okano H, Morimoto S.

Cell Stem Cell. 2022 Feb 3;29(2):189-208. doi: 10.1016/j.stem.2022.01.007.

Stimulation of the pedunculopontine and cuneiform nuclei for freezing of gait and falls in Parkinson disease: Cross-over single-blinded study and long-term follow-up

Bourilhon J, Mullie Y, Olivier C, Cherif S, Belaid H, Grabli D, Czernecki V, Karachi C, Welter ML.

Parkinsonism Relat Disord. 2022 Mar;96:13-17. doi: 10.1016/j.parkreldis.2022.01.010. Epub 2022 Jan 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias